序号 |
标题 |
次数 |
作者 |
发布时间 |
75736 |
CAS: 1920109-55-2,m-PEG4-(CH2)3-methyl ester |
98 |
WYQ |
2024-12-16 |
75737 |
p-NO2-Bn-DOTA,CAS:116052-88-1 |
86 |
h |
2024-12-16 |
75738 |
CAS: 1059189-65-9,m-PEG4-CH2-aldehyde |
67 |
WYQ |
2024-12-16 |
75739 |
Azido-mono-amide-DOTA,叠氮基-单-酰胺-DOTA |
72 |
h |
2024-12-16 |
75740 |
cas:297162-47-1,Hydroxy-PEG6-CH2CO2tBu |
64 |
WYQ |
2024-12-16 |
75741 |
cas:1807530-05-7,Hydroxy-PEG5-CH2CO2tBu |
113 |
WYQ |
2024-12-16 |
75742 |
cas:169751-72-8,Hydroxy-PEG4-CH2CO2tBu |
146 |
WYQ |
2024-12-16 |
75743 |
CAS: 518044-31-0,Hydroxy-PEG3-CH2CO2tBu |
75 |
WYQ |
2024-12-16 |
75744 |
CAS: 149299-82-1,Hydroxy-PEG2-CH2CO2tBu |
87 |
WYQ |
2024-12-16 |
75745 |
CAS: 2112737-70-7,m-PEG8-(CH2)12-phosphonic acid ethyl ester |
106 |
WYQ |
2024-12-16 |
75746 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
114 |
WYQ |
2024-12-16 |
75747 |
Butyne-DOTA-tris(t-butyl ester),CAS: 2125661-54-1 |
150 |
h |
2024-12-16 |
75748 |
pAAV-PEG3-sTRAIL质粒 |
88 |
kx |
2024-12-16 |
75749 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
111 |
WYQ |
2024-12-16 |
75750 |
DOTA-PEG4-alkyne,CAS:2080307-47-5 |
73 |
h |
2024-12-16 |
75751 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
71 |
WYQ |
2024-12-16 |
75752 |
DOTA-NHS-ester,CAS:170908-81-3 |
61 |
h |
2024-12-16 |
75753 |
99Tcm-3PEG4-RGD |
104 |
kx |
2024-12-16 |
75754 |
Azido-PEG5-CH2CO2-t-Bu(CAS号:1448451-72-6) |
65 |
WYQ |
2024-12-16 |
75755 |
DOTA螯合剂DOTA-4AMP,CAS:254444-71-8 |
79 |
h |
2024-12-16 |
75756 |
Azido-PEG4-CH2CO2-t-Bu(CAS号:864681-04-9) |
66 |
WYQ |
2024-12-16 |
75757 |
alkoxyamine-PEG4-biotin ,烷氧基胺-四聚乙二醇-生物素 |
192 |
kx |
2024-12-16 |
75758 |
DOTA-CXCR4-L,DOTA-CXCR4靶向肽 |
106 |
h |
2024-12-16 |
75759 |
DOTA-Tetrazine,DOTA-四嗪 |
74 |
h |
2024-12-16 |
75760 |
Ag~(TS)-S(CH2)_(n-1)CH3// Ga2O3/EGaIn junctions,烷基链定制 |
138 |
wyh |
2024-12-16 |
75761 |
CMP-SA-PEG4-biotin的主要结构组成及功能 |
150 |
kx |
2024-12-16 |
75762 |
DOTA-Tetrazine,DOTA-四嗪 |
83 |
h |
2024-12-16 |
75763 |
Au25(SCH2CH2Ph)18,烷基链定制 |
100 |
wyh |
2024-12-16 |
75764 |
18F-AlF-NOTA-PEG4-ZD2 , 18F-AlF-1,4,7-三氮杂环壬烷-1,4,7-三乙酸-(聚乙二醇)4-ZD2 |
100 |
kx |
2024-12-16 |
75765 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
74 |
wyh |
2024-12-16 |
75766 |
Azido-PEG3-CH2CO2-t-Bu(CAS号:172531-36-1) |
101 |
WYQ |
2024-12-16 |
75767 |
mPEG113-b-P(MTC-Cholx-co-TMCy)x+y |
102 |
kx |
2024-12-16 |
75768 |
亲脂性硼剂K[nido-7-CH3(CH2)15-7,8-C2B9H11,烷基链定制 |
113 |
wyh |
2024-12-16 |
75769 |
m-PEG6-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-88-9) |
80 |
WYQ |
2024-12-16 |
75770 |
DTPA(Gd)-PEG8-(FY)3 , DTPA(Gd)-聚乙二醇8-(FY)3 |
95 |
kx |
2024-12-16 |
75771 |
靶向CD45的抗体药物偶联物 |
113 |
kx |
2024-12-16 |
75772 |
m-PEG4-(CH2)8-phosphonic acid ethyl ester(CAS号:2028281-89-0) |
73 |
WYQ |
2024-12-16 |
75773 |
抗体偶联药物的药物连接子MCMMAF |
100 |
kx |
2024-12-16 |
75774 |
m-PEG8-(CH2)12-phosphonic acid(CAS号:2093153-86-5) |
62 |
WYQ |
2024-12-16 |
75775 |
全氟十四烷酸(PF;CF3(CF2)12COOH),烷基链定制 |
158 |
wyh |
2024-12-16 |
75776 |
靶向CD45的抗体药物偶联物 |
117 |
kx |
2024-12-16 |
75777 |
CH3(CH2)7COOH-CH3(CH2)7COO钠,烷基链定制 |
102 |
wyh |
2024-12-16 |
75778 |
HS(CH2)17CH3 ,十八硫醇,烷基链定制 |
142 |
wyh |
2024-12-16 |
75779 |
Fmoc-Val-Cit-PABC-Cn |
95 |
kx |
2024-12-16 |
75780 |
Mc-Val-Cit-PABOH ,组织蛋白酶B可切割 |
123 |
kx |
2024-12-16 |